Internal use of allicin-urotropin product - to treat bacterial, viral and fungal infections including meningitis, rabies, AIDs, tuberculosis, leprosy, plague and cancer

摘要

An 'Allicin-Urotropin' product (A), previously known only as an antibacterial for external use, is now used for internal treatment (orally, by injection or long-term infusion) of animals or humans for control of bacterial, viral, fungal and cancer disease. (A) is a stable cpd. formed from the natural garlic component allicin and urotropin. It is known from Romanian Patent 41422, and has antibacterial effects against Gram-negative and-positive, anaerobic and aerobic bacteria. USE/ADVANTAGE - Specified applications are treatment of tuberculosis, lung inflammation (bacterial, viral or fungal), bronchitis (viral or bacterial); leprosy; meningitis (viral, bacterial or fungal), plague; typhus or paratyphus A and B; influenza, herpes zoster; cholera; malaria; measles, acute and chronic liver infections; rabies, cancer (preventative) and AIDS. (A) is not toxic; retains its activity for up to 3 years after prepn. and is effective at dilutions of 1:250. It also provides the other health-promoting effects of garlic, e.g. regulation of cholesterol and sugar levels in the blood, normalisation of blood pressure, etc.